Venous Thromboembolism Treatment Market is projected to reach $4.40 billion by 2030
Meticulous Research®—a leading global
market research company, published a research report titled, ‘Venous Thromboembolism Treatment Market by Device
(Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings,
Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital,
Ambulatory Care Center) – Global Forecast to 2030.’
Download Free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5745?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=25-06-2024
According to this latest publication
from Meticulous Research®, the global venous thromboembolism
treatment market is projected to reach $4.40 billion by 2030, at a CAGR of
7.2%. The high prevalence of venous thromboembolism, rising incidence of
cancer, growing prevalence of secondary risk factors such as diabetes and
obesity, increase in orthopedic surgical procedures, and the rising demand for
minimally invasive treatment procedures are the key factors driving the growth
of the venous thromboembolism treatment market. Furthermore, the growing
accessibility and affordability of treatment options, advancements in VTE diagnosis
and treatment methods, and the market expansion in emerging economies are
expected to create market growth opportunities.
However, instances of product failure
and product recalls may restrain the market’s growth. Additionally, lack of
awareness about venous thromboembolism and increasing awareness of probable
side effects of compression garments are major challenges for market growth.
Key Players
The key players profiled in the venous
thromboembolism treatment market report are ALN Implants chirurgicaux (ALN
Surgical Implants) (France), AngioDynamics, Inc. (U.S.), Argon Medical Devices,
Inc. (U.S.), ArjoHuntleigh AB (Sweden), Boston Scientific Corporation (U.S.),
Cardinal Health, Inc. (U.S.), Cook Group Incorporated (U.S.), Koninklijke
Philips N.V. (Netherlands), DS MAREF Co., LTD (South Korea), Enovis Corporation
(U.S.), LifeTech Scientific Corporation (China), Medtronic plc (Ireland), and
Stryker Corporation (U.S.).
The global venous thromboembolism
treatment market is segmented by device (thrombectomy devices, inferior vena
cava filters {retrievable filters and permanent filters}, stockings, compression
pumps, and other devices & accessories), application (deep vein thrombosis
and pulmonary embolism), end user (hospitals, ambulatory care centers, and
other end users), and geography. The study also evaluates industry competitors
and analyzes the market at the global and regional levels.
Based on application, in 2023, the deep
vein thrombosis segment is expected to account for the largest share of the
market. The large market share of this segment is attributed to the increasing
geriatric population, rising cases of obesity, increasing cases of deep vein
thrombosis due to disease-causing lifestyle, excessive alcohol consumption, and
the growing awareness and early diagnosis of DVT. Obesity plays a significant
role in the development of venous stasis, increasing the susceptibility to DVT.
According to the World Health Organization (WHO), in 2021, the global
prevalence of obesity exceeded 1 million individuals, encompassing 340 million
adolescents, 650 million adults, and 39 million children. This number is
expected to increase by about 167 million people, including adults and
children, by 2025. Hence, the growing aging population and rising obesity rates
are anticipated to drive the demand for devices aimed at preventing deep vein
thrombosis during the forecast period
.Geographic Review
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S.,
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America,
and the Middle East & Africa. In 2022, North America is expected to account
for the largest share of the venous thromboembolism treatment market, followed
by Europe.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment